AMIDATE(TM) ETOMIDATE

CHEBI:CHEBI_750495

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1654008
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
marketing_start_date
20191212
package_marketing_start_date
20191212
active_ingredient_strength
2 mg/mL
pharm_class_pe
General Anesthesia [PE]
pharm_class
General Anesthetic [EPC]
pharm_class_epc
General Anesthetic [EPC]
nui
N0000175681
active_ingredient_name
ETOMIDATE
unii
Z22628B598
labeler_name
HF Acquisition Co LLC, DBA HealthFirst
manufacturer_name
HF Acquisition Co LLC, DBA HealthFirst
generic_name
AMIDATE(TM) ETOMIDATE
brand_name
AMIDATE(TM) ETOMIDATE
brand_name_base
AMIDATE(TM) ETOMIDATE
product_ndc
51662-1455
application_number
NDA018227
spl_id
9f42e2ee-41b5-a215-e053-2995a90a01a4
package_ndc
51662-1455-1
package_description
20 mL in 1 VIAL, SINGLE-DOSE (51662-1455-1)
spl_set_id
99847797-99eb-40d4-e053-2995a90a972a
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class